Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...
The EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's MabThera (rituximab) 1400mg solution for subcutaneous (SC) injection for the treatment of patients with common forms ...
Women with aggressive breast cancer who receive combination targeted therapy with chemotherapy prior to surgery have a slightly improved chance of staying cancer-free, researchers say. However, the improvement was not statistically ...
Tags: aggressive breast cancer, targeted therapy with chemotherapy
Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...
Roche NimbleGen and Kapa Biosystems have announced a partnership to provide an optimized next-generation sequencing (NGS) target enrichment workflow solution. Kapa Biosystems will custom manufacture NGS library preparation products for ...
Tags: Roche, Kapa Biosystems
Ocera Therapeutics has entered into a technology transfer and license deal with the Roche Group, including the Research and Early Development arms of both Genentech and Roche, for rights to its Macrocyclic Template Chemistry (MATCH) ...
Tags: Ocera Therapeutics, License Deal
Ocera Therapeutics (Nasdaq:OCRX) today announced that it has entered into a Technology Transfer and License Agreement with the Roche Group, including the Research and Early Development arms of both Genentech and Roche, for rights to its ...
Tags: Ocera Therapeutics, Roche, Macrocyclic Template Chemistry
Ventana Medical Systems (Ventana), a member of the Roche Group, has announced that its Ventana HER2/neu (4B5) rabbit monoclonal primary antibody assay is now a companion diagnostic for detecting HER2 protein expression for patients who, in ...
Tags: Ventana, Medical Systems
Roche and Prothena have agreed to jointly develop and commercialize new antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinson's disease (PD). Currently, PRX002 is in ...
Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...
Tags: Roche, Molecular Partners
Ventana Medical Systems, a member of the Roche Group, has obtained the US Food and Drug Administration’s (FDA) 510(k) approval for its Companion Algorithm ER (SP1) image analysis algorithm used with the Ventana iScan Coreo scanner ...
Tags: Breast Cancer, Analysis Algorithm
Roche announced has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for the use of four additional specimen types with the cobas CT/NG v2.0 test to help physicians diagnose Chlamydia trachomatis (CT) and Neisseria ...
FinancialForce.com, a company specializing in back office applications, has announced that it has acquired the business and assets of Less Software including the firm's supply chain management (SCM) solutions. The cloud application suite ...
Tags: Software, cloud application
Denmark-based Novo Nordisk has announced that the European Medicines Agency (EMA's) Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing of the NovoRapid PumpCart in Europe. NovoRapid PumpCart is a 1.6ml ...
Swiss drugmaker Roche has entered into a license agreement with Polyphor for the development and commercialization of its investigational macrocycle antibiotic, POL7080, to treat patients suffering from bacterial infections caused by ...
Tags: Roche, Polyphor, Antibiotic Drug